Blood and Marrow Transplant Center
1265 Union Avenue
2 Shorb BMT Clinic
Memphis, TN 38104
Direct phone: (901) 516-7000
Total transplants by cell source
- Marrow: 3
- PBSC: 54
- Cord Blood: 2
- Autologous (PBSC or Marrow): 104
About the center
Established in 2012 and located in Memphis, Tennessee, the Methodist Healthcare Blood and Marrow Transplant Program is a collaborative effort between Methodist Healthcare and the University of Tennessee Health Science Center. The program provides transplantation for adults with conditions such as leukemia, lymphoma, multiple myeloma, bone marrow failure syndromes, and aplastic anemia. Transplants are performed using all donor types. This may entail using a persons own stem cells or cells from a donor. Donor cells may come from either conventional sources such as a matched sibling or a fully matched unrelated donor or from alternative sources such as a haplo-identical (half-match relative) donor or umbilical cord blood. The program offers inpatient and outpatient services and also provides extracorporeal photopheresis. The program is accredited by FACT and AABB and continually strives to achieve patient outcomes that exceed the national average.
This center has been performing allogeneic transplants since 2012 and has been an NMDP/Be The Match transplant center since July 2016.
Adult - Jacinth Joseph, Yasser Khaled, Brion Randolph
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Information on this topic was not provided.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 86 patients.
The actual 1-year survival of these patients is 68.5%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 54.2% and 73.2%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
If you have questions about costs and financial services at this center, please call the transplant center's direct phone number.
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)
No survivorship program information is available. Contact the center for information about post-transplant care.